Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Healthcare Services Group
HCSG
$1.57B
| $616K | ﹤0.01% |
35,358
-24,648
| -41% | -$425K |
|
2627
TTM Technologies
TTMI
$13.6B
| $616K | ﹤0.01% |
49,225
-59,039
| -55% | -$816K |
|
2628
Flowserve
FLS
$10.1B
| $615K | ﹤0.01% |
21,488
+7,405
| +53% | +$236K |
|
2629
OFG Bancorp
OFG
$2.25B
| $615K | ﹤0.01% |
24,231
-72,259
| -75% | -$1.94M |
|
2630
Globant
GLOB
$1.66B
| $614K | ﹤0.01% |
3,526
+3,380
| +2,315% | +$688K |
|
|
PFC
2631
DELISTED
Premier Financial Corp. Common Stock
PFC
| $614K | ﹤0.01% |
+24,194
| New | +$653K |
|
2632
Madison Square Garden
MSGS
$9.42B
| $612K | ﹤0.01% |
4,056
+2,171
| +115% | +$352K |
|
2633
News Corp Class B
NWS
$17.9B
| $612K | ﹤0.01% |
38,612
-38,839
| -50% | -$723K |
|
|
AVNS
2634
DELISTED
Avanos Medical
AVNS
| $610K | ﹤0.01% |
22,315
-31,816
| -59% | -$914K |
|
|
ITOS
2635
DELISTED
iTeos Therapeutics
ITOS
| $610K | ﹤0.01% |
29,623
-54,376
| -65% | -$1.29M |
|
2636
Jackson Financial
JXN
$9.38B
| $610K | ﹤0.01% |
22,874
+4,049
| +22% | +$148K |
|
2637
Middlesex Water
MSEX
$1.08B
| $610K | ﹤0.01% |
6,963
-8,679
| -55% | -$778K |
|
2638
Element Solutions
ESI
$9.34B
| $607K | ﹤0.01% |
34,079
+19,367
| +132% | +$393K |
|
2639
Titan International
TWI
$471M
| $607K | ﹤0.01% |
40,200
-26,793
| -40% | -$433K |
|
2640
Axos Financial
AX
$5.89B
| $606K | ﹤0.01% |
16,903
-28,749
| -63% | -$1.1M |
|
2641
Dana Inc
DAN
$3.01B
| $604K | ﹤0.01% |
42,966
-9,230
| -18% | -$143K |
|
2642
World Kinect Corp
WKC
$1.97B
| $602K | ﹤0.01% |
29,439
-30,804
| -51% | -$756K |
|
2643
iShares MSCI Thailand ETF
THD
$367M
| $601K | ﹤0.01% |
+8,732
| New | +$642K |
|
|
HMCO
2644
DELISTED
HumanCo Acquisition Corp. Class A Common Stock
HMCO
| $601K | ﹤0.01% |
+61,113
| New | +$601K |
|
|
FINV
2645
FinVolution Group
FINV
$1.15B
| $600K | ﹤0.01% |
+126,273
| New | +$509K |
|
2646
The RMR Group
RMR
$324M
| $600K | ﹤0.01% |
21,141
+1,422
| +7% | +$41K |
|
2647
AeroVironment
AVAV
$8.51B
| $599K | ﹤0.01% |
7,292
-31,663
| -81% | -$2.81M |
|
2648
Aura Biosciences
AURA
$743M
| $598K | ﹤0.01% |
42,186
-17,511
| -29% | -$290K |
|
2649
First Community Bankshares
FCBC
$917M
| $598K | ﹤0.01% |
20,338
-1,956
| -9% | -$54.6K |
|
2650
Revolution Medicines
RVMD
$41.9B
| $598K | ﹤0.01% |
30,661
-7,052
| -19% | -$137K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 561 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.